Browsing Tag
HEALEY ALS Platform Trial
2 posts
Why investors are watching Neurizon Therapeutics (ASX: NUZ) ahead of FDA clearance for NUZ-001
Neurizon Therapeutics (ASX: NUZ) secures A$5m to fund ALS trial entry. Can NUZ-001 succeed in the HEALEY ALS Platform Trial and change the biotech landscape?
FDA delay shifts Neurizon Therapeutics (ASX: NUZ) ALS trial start — Can Q4 still deliver a win?
FDA delays decision on Neurizon’s NUZ-001 ALS trial to October, but manufacturing, regulatory, and trial readiness milestones keep Q4 start within reach.